In other words, RMRP knockdown inhibited glioma cell proliferation, facilitated glioma cell apoptosis, and weakened the resistance of glioma cells to TMZ through up-regulating ZNRF3. This evidence concerns the gene ZNRF3 and central nervous system cancer.